Attached files
Exhibit
99.2
ITEM
6. SELECTED CONSOLIDATED FINANCIAL DATA
The
following table shows selected historical consolidated financial data for our
Company adjusted for the retroactive application of Financial Accounting
Standards Board Staff Position APB 14-1, “Accounting for Convertible Debt
Instruments That May Be Settled in Cash upon Conversion (Including Partial Cash
Settlement)” (“FSP APB 14-1”), adopted by us on August 1, 2009. Effective
August 1, 2005, we adopted the provisions of SFAS No. 123(R), “Share-Based
Payment” using the modified prospective method and, as a result, periods prior
to August 1, 2005 do not reflect the recognition of stock-based compensation
expense.
Detailed
historical financial information is included in the audited consolidated
financial statements for fiscal 2009, 2008 and 2007.
Fiscal
Years Ended July 31,
(In
thousands, except per share amounts)
(As
adjusted for the retroactive application of FSP APB 14-1)
|
||||||||||||||||||||
2009
|
2008
|
2007
|
2006
|
2005
|
||||||||||||||||
Consolidated
Statement of
|
||||||||||||||||||||
Operations
Data:
|
||||||||||||||||||||
Net
sales
|
$ | 586,372 | 531,627 | 445,684 | 391,511 | 307,890 | ||||||||||||||
Cost
of sales
|
345,472 | 296,687 | 252,389 | 232,210 | 180,524 | |||||||||||||||
Gross
profit
|
240,900 | 234,940 | 193,295 | 159,301 | 127,366 | |||||||||||||||
Expenses:
|
||||||||||||||||||||
Selling,
general and administrative
|
100,171 | 85,967 | 73,312 | 67,071 | 51,819 | |||||||||||||||
Research
and development
|
50,010 | 40,472 | 32,469 | 25,834 | 21,155 | |||||||||||||||
In-process
research and development
|
6,200 | - | - | - | - | |||||||||||||||
Amortization
of intangibles
|
7,592 | 1,710 | 2,592 | 2,465 | 2,328 | |||||||||||||||
163,973 | 128,149 | 108,373 | 95,370 | 75,302 | ||||||||||||||||
Operating
income
|
76,927 | 106,791 | 84,922 | 63,931 | 52,064 | |||||||||||||||
Other
expenses (income):
|
||||||||||||||||||||
Interest
expense
|
6,396 | 7,100 | 6,820 | 6,472 | 6,181 | |||||||||||||||
Interest
income and other
|
(2,738 | ) | (14,065 | ) | (14,208 | ) | (9,243 | ) | (4,072 | ) | ||||||||||
Income
before provision for income taxes
|
73,269 | 113,756 | 92,310 | 66,702 | 49,955 | |||||||||||||||
Provision
for income taxes
|
25,744 | 40,106 | 29,673 | 23,818 | 15,506 | |||||||||||||||
Net
income
|
$ | 47,525 | 73,650 | 62,637 | 42,884 | 34,449 | ||||||||||||||
Net
income per share:
|
||||||||||||||||||||
Basic
|
$ | 1.81 | 3.05 | 2.70 | 1.88 | 1.59 | ||||||||||||||
Diluted
|
$ | 1.73 | 2.76 | 2.42 | 1.72 | 1.42 | ||||||||||||||
Weighted
average number of common shares outstanding –
basic
|
26,321 | 24,138 | 23,178 | 22,753 | 21,673 | |||||||||||||||
Weighted
average number of common and common equivalent shares outstanding –
diluted
|
29,793 | 28,278 | 27,603 | 27,324 | 27,064 |
(continued)
1
Fiscal
Years Ended July 31,
(In
thousands)
|
||||||||||||||||||||
2009
|
2008
|
2007
|
2006
|
2005
|
||||||||||||||||
Other
Consolidated Operating Data:
|
||||||||||||||||||||
Backlog
at period-end
|
$ | 549,833 | 201,122 | 129,044 | 186,007 | 153,314 | ||||||||||||||
New
orders
|
883,750 | 603,705 | 388,721 | 424,204 | 377,655 | |||||||||||||||
Research
and development expenditures - internal and customer
funded
|
64,955 | 48,224 | 36,639 | 30,243 | 24,156 |
As
of July 31,
(In
thousands)
(As
adjusted for the retroactive application of FSP APB 14-1)
|
||||||||||||||||||||
2009
|
2008
|
2007
|
2006
|
2005
|
||||||||||||||||
Consolidated
Balance Sheet Data:
|
||||||||||||||||||||
Total
assets
|
$ | 938,671 | 652,723 | 555,780 | 454,542 | 381,517 | ||||||||||||||
Working
capital
|
596,525 | 484,454 | 397,086 | 308,989 | 254,692 | |||||||||||||||
Convertible
senior notes
|
200,000 | 91,946 | 87,367 | 83,116 | 79,169 | |||||||||||||||
Other
long-term obligations
|
2,283 | - | 108 | 243 | 396 | |||||||||||||||
Stockholders’
equity
|
629,129 | 450,773 | 356,522 | 267,572 | 212,344 |
2